WEST PHARMACEUTICAL SERV INC
Reported by BILL & MELINDA GATES FOUNDATION TRUST
Reported 444,500 shares, unchanged from the prior quarter.
Reported value 4.9%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-03-31 | 99514660 |
| 2025-06-30 | 97256600 |
| 2025-09-30 | 116605685 |
| 2025-12-31 | 122299730 |
| 2026-03-31 | 111409480 |
| 2026-06-30 | 159575500 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Unchanged | 444,500 | 0 (0.0%) | 0.46% | $159,575,500 | 2026-08-14 | |
| Q1 2026 | Unchanged | 444,500 | 0 (0.0%) | 0.35% | $111,409,480 | 2026-05-15 | |
| Q4 2025 | Unchanged | 444,500 | 0 (0.0%) | 0.35% | $122,299,730 | 2026-02-17 | |
| Q3 2025 | Unchanged | 444,500 | 0 (0.0%) | 0.32% | $116,605,685 | 2025-11-14 | |
| Q2 2025 | Unchanged | 444,500 | 0 (0.0%) | 0.2% | $97,256,600 | 2025-08-14 | |
| Q1 2025 | New | 444,500 | +444,500 (0.0%) | 0.24% | $99,514,660 | 2025-05-15 |
Who else reported the position
861 managers reported WEST PHARMACEUTICAL SERV INC for Q4 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Reduced | 9,539,173 | -165,775 | 0.04% | $2,624,608,060 | 51 qtrs |
| BlackRock Inc | Added | 6,599,735 | +143,874 | 0.03% | $1,815,851,080 | 6 qtrs |
| STATE STREET CORPORATION | Added | 3,252,020 | +44,109 | 0.03% | $894,760,783 | 51 qtrs |
| Artisan Partners Limited Partnership | Added | 2,850,401 | +79,481 | 1.17% | $784,259,419 | 34 qtrs |
| THE BANK OF NEW YORK MELLON CORPORATION | Reduced | 2,662,035 | -242,674 | 0.13% | $732,432,196 | 51 qtrs |
| BROWN ADVISORY INC | Reduced | 1,943,606 | -554,476 | 0.75% | $534,770,720 | 36 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 1,869,086 | +11,962 | 0.03% | $512,249,725 | 51 qtrs |
| GENERATION INVESTMENT MANAGEMENT LLP | Added | 1,561,869 | +585,855 | 2.98% | $429,732,636 | 3 qtrs |
| MORGAN STANLEY | Added | 1,531,858 | +53,229 | 0.03% | $421,476,429 | 51 qtrs |
| T Rowe Price Investment Management Inc | Added | 1,174,962 | +473,547 | 0.2% | $323,280,000 | 14 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2025
- Filed
- February 17, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 444,500
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.